COVID-19 - a set of symptoms or a systemic pathology? Clinical lecture. Part 1. Details of multiple organ damage
Abstract
Clinical practice shows that in addition to the life-threatening condition caused by lung damage during infection with SARS-CoV-2, the virus provokes multiple organ damage and systemic endothelial inflammation, leading to serious, often fatal consequences. The review article
COVID-19 - a set of symptoms or a systemic pathology? Clinical lecture Part 2. Areplivir (favipiravir) in the treatment of patients with coronavirus infection: background of use and first results
Abstract
Clinical practice shows that in addition to a life-threatening condition caused by lung damage, the SARS-CoV-2 virus provokes multiple organ damage and systemic endothelial inflammation, leading to serious, often fatal consequences. The complex pathophysiology of the virus
The efficacy of etiotropic therapy for a new coronavirus infection with Areplevir (favipiravir), depending on the time of initiation of treatment (clinical observation)
Abstract
The current millennium has been marked by the emergence of 3 epidemics of coronavirus infection: severe acute respiratory syndrome (SARS, SARS-CoV or atypical pneumonia), Middle East respiratory syndrome (MERS-CoV) and, over the past year, severe acute respiratory syndrome
Obesity and COVID-19: a fatal link
Abstract
Obesity is an important predictor of risk for severe COVID-19, critical illness and death, according to available data. The causes include endocrine and metabolic disorders associated with obesity, including impaired insulin sensitivity, chronic inflammation, and the